TTI-101
2022-0625
Phase 2 small_molecule terminated
Quick answer
TTI-101 for Head and Neck Squamous Cell Carcinoma is a Phase 2 program (small_molecule) at Tvardi Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tvardi Therapeutics
- Indication
- Head and Neck Squamous Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated